Mettler-Toledo International (NYSE:MTD) Trading Down 4.5%

Shares of Mettler-Toledo International Inc. (NYSE:MTD) dropped 4.5% on Monday . The company traded as low as $1,481.97 and last traded at $1,486.80. Approximately 2,368 shares were traded during trading, a decline of 98% from the average daily volume of 108,245 shares. The stock had previously closed at $1,556.84.

MTD has been the topic of a number of analyst reports. Robert W. Baird boosted their price objective on shares of Mettler-Toledo International from $1,303.00 to $1,455.00 and gave the company a “neutral” rating in a research report on Friday, July 30th. They noted that the move was a valuation call. Wells Fargo & Company boosted their price objective on shares of Mettler-Toledo International from $1,350.00 to $1,500.00 and gave the company an “equal weight” rating in a research report on Friday, July 30th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $1,195.71.

The stock’s fifty day moving average price is $1,530.54 and its 200 day moving average price is $1,365.41. The company has a debt-to-equity ratio of 8.37, a current ratio of 1.25 and a quick ratio of 0.88. The stock has a market capitalization of $34.16 billion, a P/E ratio of 52.10, a PEG ratio of 2.86 and a beta of 1.00.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, July 29th. The medical instruments supplier reported $8.10 EPS for the quarter, topping the Zacks’ consensus estimate of $7.64 by $0.46. The firm had revenue of $924.35 million for the quarter, compared to analysts’ expectations of $879.96 million. Mettler-Toledo International had a net margin of 20.51% and a return on equity of 263.52%. During the same period in the prior year, the business posted $5.29 earnings per share. On average, sell-side analysts expect that Mettler-Toledo International Inc. will post 32.86 earnings per share for the current year.

In other Mettler-Toledo International news, Director Oliver A. Filliol sold 7,500 shares of the stock in a transaction dated Monday, August 23rd. The shares were sold at an average price of $1,533.41, for a total transaction of $11,500,575.00. Following the transaction, the director now directly owns 26,031 shares in the company, valued at approximately $39,916,195.71. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider La Guerroniere Marc De sold 3,627 shares of the stock in a transaction dated Tuesday, August 17th. The stock was sold at an average price of $1,536.74, for a total transaction of $5,573,755.98. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,096 shares of company stock worth $50,014,662. Company insiders own 3.00% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the business. Marks Group Wealth Management Inc lifted its position in shares of Mettler-Toledo International by 3.7% during the second quarter. Marks Group Wealth Management Inc now owns 198 shares of the medical instruments supplier’s stock valued at $274,000 after buying an additional 7 shares during the last quarter. Lido Advisors LLC lifted its position in shares of Mettler-Toledo International by 1.7% during the second quarter. Lido Advisors LLC now owns 408 shares of the medical instruments supplier’s stock valued at $565,000 after buying an additional 7 shares during the last quarter. Rafferty Asset Management LLC lifted its position in shares of Mettler-Toledo International by 1.6% during the first quarter. Rafferty Asset Management LLC now owns 519 shares of the medical instruments supplier’s stock valued at $600,000 after buying an additional 8 shares during the last quarter. Granite Investment Partners LLC raised its position in shares of Mettler-Toledo International by 0.4% in the 1st quarter. Granite Investment Partners LLC now owns 2,238 shares of the medical instruments supplier’s stock valued at $2,586,000 after purchasing an additional 8 shares during the last quarter. Finally, TCI Wealth Advisors Inc. raised its position in shares of Mettler-Toledo International by 50.0% in the 2nd quarter. TCI Wealth Advisors Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 8 shares during the last quarter. 92.56% of the stock is owned by institutional investors and hedge funds.

Mettler-Toledo International Company Profile (NYSE:MTD)

Mettler-Toledo International, Inc is a supplier of precision instruments and services. The firm manufactures weighing instruments for use in laboratory, industrial, packaging, logistics, and food retailing applications. It also manufactures several related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and also, metal detection and other end-of-line inspection systems used in production and packaging and provides solutions for use in certain process analytics applications.

Featured Article: Quick Ratio

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.